AESKULISA ANA 8PRO

Extractable Antinuclear Antibody, Antigen And Control

AESKU, INC

The following data is part of a premarket notification filed by Aesku, Inc with the FDA for Aeskulisa Ana 8pro.

Pre-market Notification Details

Device IDK032469
510k NumberK032469
Device Name:AESKULISA ANA 8PRO
ClassificationExtractable Antinuclear Antibody, Antigen And Control
Applicant AESKU, INC 8880 NORTHWEST 18TH TERRACE Miami,  FL  33172
ContactStanley Ammons
CorrespondentStanley Ammons
AESKU, INC 8880 NORTHWEST 18TH TERRACE Miami,  FL  33172
Product CodeLLL  
CFR Regulation Number866.5100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2003-08-11
Decision Date2003-12-16

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
04250289503013 K032469 000
B24235E6PHUE010 K032469 000
04250289500425 K032469 000
04250289500456 K032469 000
04250289500463 K032469 000
04250289500487 K032469 000
04250289500524 K032469 000
04250289500531 K032469 000
04250289500555 K032469 000
04250289502917 K032469 000
04250289502931 K032469 000
04250289502948 K032469 000
04250289502962 K032469 000
04250289502986 K032469 000
04250289502993 K032469 000
B24235ANAHUE010 K032469 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.